Explore 3 Stock Ideas & Industry Insights Download Free Report

News

What ADMA Biologics (NASDAQ:ADMA) Investors Should Know as Shares Jump 19% Pre-Market Today on Raised Profit Guidance

ADMA is a vertically integrated commercial biopharmaceutical company based in Ramsey, New Jersey. It develops, manufactures and markets specialty plasma-derived biologics for immunodeficient patients and others at risk of certain infectious diseases. Its three FDA-approved products are ASCENIV and BIVIGAM, both intravenous immune globulin …

Nitish Kishor | 05 November 2026

BD (NYSE:BDX) Pulls Back 6% Pre-Market After Run to 52-Week High as Fiscal 2027 EPS Outlook Lands Near Consensus

Fourth-quarter revenue of $5.27 billion compared with an expected $5.11 billion, and adjusted EPS of $4.15 compared with $4.07.GAAPEPS was $2.52, up from $1.20 a year earlier.

Nitish Kishor | 05 November 2026

Why Is Caris Life Sciences (NASDAQ:CAI) Stock Down 16% Pre-Market Today?

Caris is an Irving, Texas-based precision oncology company that applies artificial intelligence to molecular data. It combines whole exome, whole transcriptome and whole genome sequencing withMachine Learningto build a large clinico-genomic database, which powers its tissue-based MI Profile and the blood-based Caris Assure.

Nitish Kishor | 05 November 2026

Enovis (NYSE:ENOV) Raises Guidance and Doubles Its Buyback in One Morning, Lifting Shares 9% Pre-Market

Enovis is a Dallas-based, orthopedic-focused medical technology company. Its Prevention and Recovery segment covers bracing, hot and cold therapy, bone growth stimulators and rehabilitation products under brands such as DJO, DonJoy and Aircast. Its Reconstructive segment sells hip, knee, shoulder, extremity, foot and ankle …

Nitish Kishor | 05 November 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) Penny Stock Rises 7% Pre-Market Today as Heart Study Overenrolls and Type 1 Diabetes Filing Nears

Lexicon is a Woodlands, Texas-based biopharmaceutical company that uses gene science to discover, develop and commercialize oral small-molecule medicines for cardiometabolic disease and chronic pain. Its lead asset, sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, is sold in the United States as INPEFA for …

Nitish Kishor | 05 November 2026

Myriad Genetics (NASDAQ:MYGN) Surges 12% Pre-Market Today Despite a Slight Annual Revenue Dip as Prenatal Unit Sale Lifts Outlook

Myriad is a Salt Lake City-based molecular diagnostics company that runs a fee-for-service testing model. Its portfolio covers hereditary cancer risk, including MyRisk, oncology companion diagnostics and prognostics, prenatal and reproductive health tests such as Prequel and Foresight, and the GeneSight mental health pharmacogenomic …

Nitish Kishor | 05 November 2026

Surprise Profit and Higher 2026 Outlook Lift Oscar Health (NYSE:OSCR) 4% Pre-Market Today

Oscar is a New York-based, technology-driven health insurer founded in 2012. It sells individual and family plans, along with small-group and CHOICE (ICHRA) offerings, mainly on the ACA marketplace. Its footprint covers 573 counties in 20 states and is planned to expand to 713 …

Nitish Kishor | 05 November 2026

Slower System Placements and Missed Estimates Send PROCEPT BioRobotics (NASDAQ:PRCT) Down 9% Pre-Market Today

PROCEPT is a San Jose, California-based commercial-stage surgical robotics company focused on urology and the treatment of benign prostatic hyperplasia. Its AquaBeam and next-generation, AI-enabled HYDROS Robotic Systems deliver Aquablation therapy, an image-guided, heat-free robotic waterjet procedure that removes prostate tissue. Hospitals and surgery …

Nitish Kishor | 05 November 2026

Why Is Revolution Medicines (NASDAQ:RVMD) Stock Up 6% Pre-Market Today?

Revolution Medicines is a Redwood City, California-based oncology company developing oral targeted therapies for RAS-addicted cancers, including pancreatic, lung and colorectal tumors. Its pipeline is built on a proprietary tri-complex platform that produces RAS(ON) inhibitors.

Nitish Kishor | 05 November 2026

STAAR Surgical (NASDAQ:STAA): What's Behind the 3% Pre-Market Rise Today

STAAR is a Lake Forest, California-based maker of implantable phakic intraocular lenses. Its EVO family of Implantable Collamer Lenses corrects myopia, hyperopia, astigmatism and presbyopia without removing corneal tissue. The company has sold more than 4 million lenses in over 75 countries, and about …

Nitish Kishor | 05 November 2026
Support

Hi! How can we help you today?

Loading…